Global In Vitro Diagnostics (IVD) Quality Control Market
Global In Vitro Diagnostics (IVD) Quality Control Market Size to Reach $1.6 Billion by 2030
[London, United Kingdom] – [1st June 2023] – The global In Vitro Diagnostics (IVD) Quality Control Market size is projected to reach USD 1.6 billion by 2030, according to a new report by Pharmanucleus. The market is expected to grow at a CAGR of 5.4% from 2023 to 2030.
The growth of the In Vitro Diagnostics (IVD) Quality Control Market is being driven by a number of factors, including the increasing number of accredited clinical laboratories, the rising geriatric population, the rising demand for external quality assessment programs, the increasing adoption of point-of-care (POC) instruments in developed regions, and the increasing adoption of third-party quality controls.
The In Vitro Diagnostics (IVD) Quality Control Market is segmented by product type, application, end user, and region. By product type, the market is segmented into quality control products and data management solutions. By application, the market is segmented into clinical chemistry, immunochemistry/immunoassay, hematology, molecular diagnostics, coagulation and hemostasis, microbiology, and others. By end user, the market is segmented into clinical laboratories and research laboratories.
The North American region is expected to be the largest market for IVD quality control, followed by Europe and Asia Pacific. The growth of the market in North America is being driven by the presence of a large number of accredited clinical laboratories, the rising geriatric population, and the increasing demand for external quality assessment programs. The growth of the market in Europe is being driven by the increasing adoption of POC instruments and the increasing adoption of third-party quality controls. The growth of the market in Asia Pacific is being driven by the rising number of accredited clinical laboratories and the increasing demand for external quality assessment programs.
The key players in the In Vitro Diagnostics (IVD) Quality Control Market include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, SeraCare Life Sciences Inc., bioMerieux Inc., and ZeptoMetrix Corporation. These players are focusing on developing innovative products and expanding their geographic reach to gain a competitive advantage in the market.
For more information about the report and to request a sample copy, please visit
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.